Allen Institute for Artificial Intelligence logo

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Mitomycin and Vitamin K


Vitamin K

Research Papers that Mention the Interaction

Despite preclinical evidence indicating that menadione pretreatment enhances the cytotoxicity of mitomycin C , our study documents the resistance of advanced gastrointestinal cancers, particularly colorectal cancer, to mitomycin C modulated by menadione.
Journal of Cancer Research and Clinical Oncology  •  2005  |  View Paper
All three patients treated with menadione at 8.0 g/m2 and the single patient treated at 4.0 g/m2 with mitomycin C at 5 mg/m2 developed clinically significant hemolysis despite the presence of red blood cell glucose-6-phosphate dehydrogenase.
Cancer Chemotherapy and Pharmacology  •  2004  |  View Paper
In addition, PMS, MEN and MB were found to decrease the cytotoxicity of MMC , by 90, 63 and 29%, respectively, at concentrations that were themselves completely nontoxic.
European journal of cancer & clinical oncology  •  1989  |  View Paper
MITO and vitamin K3 in combination effected an enhanced inhibition of [3H]thymidine (DNA synthesis) and [3H]uridine (RNA synthesis) and also Increased the life span of the sensitive and resistant tumor-bearing animals.
Vitamin K3 potentiated the antitumor effects of MITO in P388/S and P388/ ADR tumor cells as monitored by inhibition of tumor cell survival (MTT assay).
Tumori  •  1991  |  View Paper